FDA Drug Recalls

Recalls / Class II

Class IID-0455-2025

Product

Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-30

Brand name
Fluoxetine
Generic name
Fluoxetine
Active ingredient
Fluoxetine Hydrochloride
Route
Oral
NDCs
13668-443, 13668-473
FDA application
ANDA206937
Affected lot / code info
Lot# BDX6K001; Exp. Date 06/30/2025

Why it was recalled

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Recalling firm

Firm
Torrent Pharma Inc.
Manufacturer
Torrent Pharmaceuticals Limited
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
106 Allen Rd Ste 305, N/A, Basking Ridge, New Jersey 07920-3851

Distribution

Quantity
3672 Bottles
Distribution pattern
U.S. Nationwide.

Timeline

Recall initiated
2025-05-27
FDA classified
2025-06-02
Posted by FDA
2025-06-11
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0455-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Fluoxetine · FDA Drug Recalls